𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy results using a novel hidradenitis suppurativa endpoint, HiSCR (hidradenitis suppurativa clinical response), from the placebo-controlled phase of a phase 2 adalimumab study

Book ID: 122550842
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 51 KB
Volume: 70
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2014.01.176

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy Results Using a Novel Hidradeni

Efficacy Results Using a Novel Hidradenitis Suppurativa Endpoint, Hiscr (Hidradenitis Suppurativa Clinical Response), From The Placebo-Controlled Phase of a Phase 2 Adalimumab Study

✍ Scheinfeld, N.S.; Sobell, J.M.; Gu, Y.; Sood, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A novel hidradenitis suppurativa efficac

A novel hidradenitis suppurativa efficacy variable, HiSCR (hidradenitis suppurativa clinical response), is responsive to change with adalimumab therapy: Results of a phase II study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy and safety of adalimumab in tre

Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety of adalimumab for mo

Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Adalimumab improves health-related quali

Adalimumab improves health-related quality of life and work productivity in patients with hidradenitis suppurativa: Results from a placebo-controlled phase II trial

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy and safety of adalimumab treatm

Efficacy and safety of adalimumab treatment in women with moderate to severe hidradenitis suppurativa: Analysis from the placebo-controlled portion of a phase II, randomized, double-blind study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB